20 research outputs found
The Influence of Coronary Artery Disease in the Development of Aortic Stenosis and the Importance of the Albumin Redox State.
Calcific aortic valve and coronary artery diseases are related cardiovascular pathologies in which common processes lead to the calcification of the corresponding affected tissue. Among the mechanisms involved in calcification, the oxidative stress that drives the oxidation of sulfur-containing amino acids such ascysteines is of particular interest. However, there are important differences between calcific aortic valve disease and coronary artery disease, particularly in terms of the reactive oxygen substances and enzymes involved. To evaluate what effect coronary artery disease has on aortic valves, we analyzed valve tissue from patients with severe calcific aortic stenosis with and without coronary artery disease. Proteins and peptides with oxidized cysteines sites were quantified, leading to the identification of 16 proteins with different levels of expression between the two conditions studied, as well as differences in the redox state of the tissue. We also identified two specific sites of cysteine oxidation in albumin that have not been described previously. These results provide evidence that coronary artery disease affects valve calcification, modifying the molecular profile of aortic valve tissue. In addition, the redox proteome is also altered when these conditions coincide, notably affecting human serum albumin.This research was funded by the Junta de Comunidades de Castilla-La Mancha (JCCM,
co-funded by the European Social Fund, SBPLY/19/180501/000226), the Instituto de Salud Carlos
III through the project PI18/00995, PI21/00384 (co-funded by European Regional Development
Fund/European Social Fund—“Investing in your future”) Sociedad Española de Cardiología, 2020,
Grant PRB3 (IPT17/0019—ISCIII-SGEFI/ERDF), Spanish Ministry of Science, Innovation and Universities (PGC2018-097019-B-I00) and “la Caixa” Banking Foundation (project code HR17-00247). These
results are aligned with the Spanish initiative on the Human Proteome Project (SpHPP).S
Valvular Aortic Stenosis: A Proteomic Insight
Calcified aortic valve disease is a slowly progressive disorder that ranges from mild valve thickening with no obstruction of blood flow, known as aortic sclerosis, to severe calcification with impaired leaflet motion or aortic stenosis. In the present work we describe a rapid, reproducible and effective method to carry out proteomic analysis of stenotic human valves by conventional 2-DE and 2D-DIGE, minimizing the interference due to high calcium concentrations. Furthermore, the protocol permits the aortic stenosis proteome to be analysed, advancing our knowledge in this area
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy
Journal Article; Research Support, Non-U.S. Gov't;BACKGROUND. Either higher levels of initial DNA damage or lower levels of radiation-induced apoptosis in peripheral blood lymphocytes have been associated to increased risk for develop late radiation-induced toxicity. It has been recently published that these two predictive tests are inversely related. The aim of the present study was to investigate the combined role of both tests in relation to clinical radiation-induced toxicity in a set of breast cancer patients treated with high dose hyperfractionated radical radiotherapy. METHODS. Peripheral blood lymphocytes were taken from 26 consecutive patients with locally advanced breast carcinoma treated with high-dose hyperfractioned radical radiotherapy. Acute and late cutaneous and subcutaneous toxicity was evaluated using the Radiation Therapy Oncology Group morbidity scoring schema. The mean follow-up of survivors (n = 13) was 197.23 months. Radiosensitivity of lymphocytes was quantified as the initial number of DNA double-strand breaks induced per Gy and per DNA unit (200 Mbp). Radiation-induced apoptosis (RIA) at 1, 2 and 8 Gy was measured by flow cytometry using annexin V/propidium iodide.
RESULTS. Mean DSB/Gy/DNA unit obtained was 1.70 ± 0.83 (range 0.63-4.08; median, 1.46). Radiation-induced apoptosis increased with radiation dose (median 12.36, 17.79 and 24.83 for 1, 2, and 8 Gy respectively). We observed that those "expected resistant patients" (DSB values lower than 1.78 DSB/Gy per 200 Mbp and RIA values over 9.58, 14.40 or 24.83 for 1, 2 and 8 Gy respectively) were at low risk of suffer severe subcutaneous late toxicity (HR 0.223, 95%CI 0.073-0.678, P = 0.008; HR 0.206, 95%CI 0.063-0.677, P = 0.009; HR 0.239, 95%CI 0.062-0.929, P = 0.039, for RIA at 1, 2 and 8 Gy respectively) in multivariate analysis. CONCLUSIONS. A radiation-resistant profile is proposed, where those patients who presented lower levels of initial DNA damage and higher levels of radiation induced apoptosis were at low risk of suffer severe subcutaneous late toxicity after clinical treatment at high radiation doses in our series. However, due to the small sample size, other prospective studies with higher number of patients are needed to validate these results.This work was subsidized by a grant from the Ministerio de Educación y Ciencia (CICYT: SAF 2004-00889) and Fundación del Instituto Canario de Investigación del Cáncer (FICIC).Yes2011-0
Proteomic Profile of Human Aortic Stenosis: Insights into the Degenerative Process
This work was supported by grants from the Instituto de Salud Carlos III (FISPI070537,PI080970),Fondo de Investigación Sanitaria de Castilla la Mancha (FISCAM,PI2008/08), Fondo de Investigación Sanitaria de Castilla la Mancha (FISCAM PI2008/28) and Fondos Feder-Redes Telemáticas de Investigación Cooperativa (RD06/0014/1015)Degenerative aortic stenosis is the most common worldwide cause of valve replacement. While it shares certain risk factors with coronary artery disease, it is not delayed or reversed by reducing exposure to risk factors (e.g., therapies that lower lipids). Therefore, it is necessary to better understand its pathophysiology for preventive measures to be taken. In this work, aortic valve samples were collected from 20 patients that underwent aortic valve replacement (55% males, mean age of 74 years) and 20 normal control valves were obtained from necropsies (40% males, mean age of 69 years). The proteome of the samples was analyzed by quantitative differential electrophoresis (2D-DIGE) and mass spectrometry, and 35 protein species were clearly increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin, serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide dismutase Cu–Zn, serum amyloid P-component, glutathione S-transferase-P, fatty acid-binding protein, transthyretin, and fibrinogen gamma. By contrast, 8 protein species were decreased (transgelin, haptoglobin, glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins identified play a significant role in cardiovascular processes, such as fibrosis, homeostasis, and coagulation. The significant changes observed in the abundance of key cardiovascular proteins strongly suggest that they can be involved in the pathogenesis of degenerative aortic stenosis. Further studies are warranted to better understand this process before we can attempt to modulate it.Depto. de Genética, Fisiología y MicrobiologíaFac. de Ciencias BiológicasTRUEpu
Inside human aortic stenosis: a proteomic analysis of plasma
This work was supported by grants from the Instituto de Salud Carlos III (FIS PI070537, CP09/00229), Fondo de Investigación Sanitaria de Castilla la Mancha (FISCAM, PI2008/28 and PI2008/08) and Redes Temáticas de Investigación Cooperativa (FONDOS FEDER, RD06/0014/1015), CNIC.Valvular aortic stenosis (AS) produces a slowly progressive obstruction in left ventricular outflow track. For this reason, aortic valve replacement is warranted when the valvular stenosis is hemodinamically significant, becoming the most common worldwide cause of aortic valve surgery. Recent epidemiologic studies have revealed an association between degenerative AS and cardiovascular risk factors for atherosclerosis, althought reducing the exposure to such factors and statin therapies both fail to delay or reverse the pathology. Hence, a deeper understanding of the pathophysiology of this disease is required to identify appropriate preventive measures. A proteomic analysis of plasma will permit to know and identify the changes in protein expression induced by AS in this tissue. Using two-dimensional difference gel electrophoresis (2D-DIGE) followed by mass spectrometry (MS), we compared the crude (not pre-fractioned) and pre-fractioned plasma from AS patients and control subjects. We sought to identify plasma proteins whose expression is modified in AS. In addition we investigated if crude plasma presented some alterations in the more abundant proteins since to date, has never been studied before. We also further investigated the link between this disease and atherosclerosis with a view to identifying new potential markers and therapeutic targets.Depto. de Genética, Fisiología y MicrobiologíaFac. de Ciencias BiológicasTRUEpu
Proteomic Profile of Human Aortic Stenosis: Insights into the Degenerative Process
Degenerative aortic stenosis is the most common worldwide
cause
of valve replacement. While it shares certain risk factors with coronary
artery disease, it is not delayed or reversed by reducing exposure
to risk factors (e.g., therapies that lower lipids). Therefore, it
is necessary to better understand its pathophysiology for preventive
measures to be taken. In this work, aortic valve samples were collected
from 20 patients that underwent aortic valve replacement (55% males,
mean age of 74 years) and 20 normal control valves were obtained from
necropsies (40% males, mean age of 69 years). The proteome of the
samples was analyzed by quantitative differential electrophoresis
(2D-DIGE) and mass spectrometry, and 35 protein species were clearly
increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin,
serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide
dismutase Cu–Zn, serum amyloid P-component, glutathione S-transferase-P,
fatty acid-binding protein, transthyretin, and fibrinogen gamma. By
contrast, 8 protein species were decreased (transgelin, haptoglobin,
glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins
identified play a significant role in cardiovascular processes, such
as fibrosis, homeostasis, and coagulation. The significant changes
observed in the abundance of key cardiovascular proteins strongly
suggest that they can be involved in the pathogenesis of degenerative
aortic stenosis. Further studies are warranted to better understand
this process before we can attempt to modulate it
Proteomic Profile of Human Aortic Stenosis: Insights into the Degenerative Process
Degenerative aortic stenosis is the most common worldwide
cause
of valve replacement. While it shares certain risk factors with coronary
artery disease, it is not delayed or reversed by reducing exposure
to risk factors (e.g., therapies that lower lipids). Therefore, it
is necessary to better understand its pathophysiology for preventive
measures to be taken. In this work, aortic valve samples were collected
from 20 patients that underwent aortic valve replacement (55% males,
mean age of 74 years) and 20 normal control valves were obtained from
necropsies (40% males, mean age of 69 years). The proteome of the
samples was analyzed by quantitative differential electrophoresis
(2D-DIGE) and mass spectrometry, and 35 protein species were clearly
increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin,
serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide
dismutase Cu–Zn, serum amyloid P-component, glutathione S-transferase-P,
fatty acid-binding protein, transthyretin, and fibrinogen gamma. By
contrast, 8 protein species were decreased (transgelin, haptoglobin,
glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins
identified play a significant role in cardiovascular processes, such
as fibrosis, homeostasis, and coagulation. The significant changes
observed in the abundance of key cardiovascular proteins strongly
suggest that they can be involved in the pathogenesis of degenerative
aortic stenosis. Further studies are warranted to better understand
this process before we can attempt to modulate it
Proteomic Profile of Human Aortic Stenosis: Insights into the Degenerative Process
Degenerative aortic stenosis is the most common worldwide
cause
of valve replacement. While it shares certain risk factors with coronary
artery disease, it is not delayed or reversed by reducing exposure
to risk factors (e.g., therapies that lower lipids). Therefore, it
is necessary to better understand its pathophysiology for preventive
measures to be taken. In this work, aortic valve samples were collected
from 20 patients that underwent aortic valve replacement (55% males,
mean age of 74 years) and 20 normal control valves were obtained from
necropsies (40% males, mean age of 69 years). The proteome of the
samples was analyzed by quantitative differential electrophoresis
(2D-DIGE) and mass spectrometry, and 35 protein species were clearly
increased in aortic valves, including apolipoprotein AI, alpha-1-antitrypsin,
serum albumin, lumican, alfa-1-glycoprotein, vimentin, superoxide
dismutase Cu–Zn, serum amyloid P-component, glutathione S-transferase-P,
fatty acid-binding protein, transthyretin, and fibrinogen gamma. By
contrast, 8 protein species were decreased (transgelin, haptoglobin,
glutathione peroxidase 3, HSP27, and calreticulin). All of the proteins
identified play a significant role in cardiovascular processes, such
as fibrosis, homeostasis, and coagulation. The significant changes
observed in the abundance of key cardiovascular proteins strongly
suggest that they can be involved in the pathogenesis of degenerative
aortic stenosis. Further studies are warranted to better understand
this process before we can attempt to modulate it
Modification of the Secretion Pattern of Proteases, Inflammatory Mediators, and Extracellular Matrix Proteins by Human Aortic Valve is Key in Severe Aortic Stenosis
This work wa supported by grants from the Instituto de Salud Carlos III (FISPI070537, FISPI080970, FISPI080920, FIS IF08/ FIG.6.SRM results in crude plasma(n 43patientsandn 37controls) forgelsolin.A,Graphical representation of the abundance and representative extracted ionchromatogramsof significant transitions.B,ROC curve, calculated with the three significant transitions measured by peptide for atotal of twopeptides. ValveSecretomeisKeyin Human Aortic Stenosis Molecular & Cellular Proteomics12.9 24373667-1, RD07/0064/0023, PI11/02239, PI11/01401, CP09/00229), Fondo de Investigación Sanitaria de Castilla la Mancha (FISCAM, PI2008/08; FISCAMPI2008/28) and Redes Temáticas de Investigación Cooperativa (FONDOS FEDER,RD06/0014/1015,RD12/0042/ 0071),CNIC.One of the major challenges in cardiovascular medicine is to identify candidate biomarker proteins. Secretome analysis is particularly relevant in this search as it focuses on a subset of proteins released by a cell or tissue under certain conditions. The sample can be considered as a plasma subproteome and it provides a more direct approximation to the in vivo situation. Degenerative aortic stenosis is the most common worldwide cause of valve replacement. Using a proteomic analysis of the secretome from aortic stenosis valves we could identify candidate markers related to this pathology, which may facilitate early diagnosis and treatment. For this purpose, we have designed a method to validate the origin of secreted proteins, demonstrating their synthesis and release by the tissue and ruling out blood origin. The nLC-MS/MS analysis showed the labeling of 61 proteins, 82% of which incorporated the label in only one group. Western blot and selective reaction monitoring differential analysis, revealed a notable role of the extracellular matrix. Variation in particular proteins such as PEDF, cystatin and clusterin emphasizes the link between aortic stenosis and atherosclerosis. In particular, certain proteins variation in secretome levels correlates well, not only with label incorporation trend (only labeled in aortic stenosis group) but, more importantly, with alterations found in plasma from an independent cohort of samples, pointing to specific candidate markers to follow up in diagnosis, prognosis, and therapeutic intervention.Depto. de Genética, Fisiología y MicrobiologíaFac. de Ciencias BiológicasTRUEpu